
Drugs IPOs Depend o...


| Price and Volume | |
|---|---|
| Recent Price | 22.73 |
| 52 Week High | 25.26 |
| 52 Week Low | 13.06 |
| Avg. Daily Vol. (Mil) | 8.63 |
| Beta (3 year) | 0.76 |
| Share Related Items | |
| Mkt Cap (Mil) | 15,834.51 |
| Shares Out (Mil) | 696.63 |
| Float (Mil) | 702.86 |
| Dividend Information | |
| Yield % | 2.60 |
| Annual Dividend | 0.60 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.00 |
| Current Ratio | 1.10 |
| LT Debt/ Equity | 0.39 |
| Total Debt / Equity | 0.57 |
| Valuation Ratios | |
| Price Earnings | 21.00 |
| Price/Sales | 2.29 |
| Price/Book | 2.92 |
| Price/Cash Flow | 10.80 |
| Per Share Data | |
| Earnings | 1.08 |
| Sales | 9.91 |
| Book Value | 7.78 |
| Cash Flow | 2.10 |
| Business Summary | |
|---|---|
| Symantec Corp provides security, storage and systems management solutions to help businesses and consumers secure and manage their information. | |
| General Information | |
| 350 Ellis Street
Mountain View, CA 94043 |
|
| www.symantec.com | |
| Industry : Computer Software & Services | |
| Sector: Technology | |
| Employees: 21500 | |
| CEO: Stephen M. Bennett | |
| Short Interest | |
| Current Month (Mil) | 15.09 |
| Previous Month (Mil) | 20.37 |
| Short Interest Ratio (Days) | 1.50 |
| Management Effectiveness | |
| Return on Equity | 14.10 |
| Return on Assets | 5.30 |
| Return on Investments | 10.20 |
| Profitability | |
| Gross Margin | 89.00 |
| EBIT Margin | 16.80 |
| Profit Margin | 11.10 |